131 results on '"Schreiber, Theodore"'
Search Results
2. IDIOPATHIC DILATED CARDIOMYOPATHY AS A RESULT OF COXSACKIE B VIRUS INFECTION
3. DEHISCENCE OF A BIOPROSTHETIC TRICUSPID VALVE IN A PATIENT WITH EBSTEIN’S ANOMALY
4. THE USE OF METHYLENE BLUE AND ECMO IN THE TREATMENT OF β BLOCKER OVERDOSE
5. TCT-34 Reduction of Infarct Size in Anterior ST-Segment Elevation Myocardial Infarction (STEMI) With LAD Occlusion and LV Unloading Using a Micro-axial Pump for 30 Minutes Before PCI: Per-Protocol Analysis of the STEMI Door to Unload (DTU) Pilot Study
6. Peripartum Cardiomyopathy: Predictors of Recovery and Current State of Implantable Cardioverter-Defibrillator Use
7. Impact of Sex on Morbidity and Mortality Rates After Lower Extremity Interventions for Peripheral Arterial Disease: Observations From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
8. METASTATIC RIGHT VENTRICULAR MASS AS STEMI MIMIC
9. UNRAVELING THE ENIGMA: A CASE OF REVERSE TAKOTSUBO SYNDROME WITH CARDIOGENIC SHOCK
10. RACIAL DIFFERENCES IN CLINICAL FEATURES AND OUTCOMES OF PATIENTS UNDERGOING HIGH RISK PCI WITH HEMODYNAMIC SUPPORT IN A CONTEMPORARY COHORT
11. TCT CONNECT-172 Clinical Features and Outcomes of Acute Myocardial Infarction and Cardiogenic Shock Patients Treated With Impella: Early Compared With Recent Experience
12. TCT-813 Culprit-Vessel Versus Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: Insights From the National Cardiogenic Shock Initiative
13. TCT-25 Comparative Safety and Effectiveness of Orbital and Rotational Atherectomy in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
14. TCT-368 Axillary Artery Access in the Setting of Cardiogenic Shock and Severe Peripheral Arterial Disease
15. TCT-757 Axillary Artery Access for Mechanical Circulatory Support Devices in Patients with Prohibitive Peripheral Arterial Disease Presenting with Cardiogenic Shock
16. TCT-604 Outcome of High Risk Percutaneous Coronary Intervention: Gender-Based Analysis
17. TCT-570 In-Hospital Outcomes of Transcatheter Aortic Valve Replacement After Non-Elective Admission in Comparison with Elective Admission
18. TCT-83 Lactate and Cardiac Power Output Measurements at 12-24 Hours Reliably Predict Outcomes in Cardiogenic Shock: Insights from the National Cardiogenic Shock Initiative
19. TCT-533 Predictors of High Hospital Cost After Transcatheter Aortic Valve Replacement in the United States: Analysis of Nationwide Inpatient Sample Database
20. TCT-694 Outcome of High Risk Percutaneous Coronary Intervention in Octogenarians: Insight from the from the cVAD Registry
21. TRANSCATHETER VERSUS SURGICAL VALVE REPLACEMENT IN NON-ELDERLY (AGE LESS THAN 65): IN-HOSPITAL OUTCOMES FROM THE NATIONAL INPATIENT SAMPLE
22. AXILLARY ARTERY AS ALTERNATIVE ACCESS FOR MECHANICAL CIRCULATORY SUPPORT DEVICES: TECHNIQUE AND OUTCOMES FROM A HIGH VOLUME CENTER
23. PATENT FORAMEN OVALE CLOSURE VERSUS MEDICAL THERAPY TO PREVENT RECURRENT STROKE: A META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS
24. ROTATIONAL ATHERECTOMY VERSUS STANDARD PCI IN PATIENTS WITH CALCIFIED CORONARY LESIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
25. USE OF PERCUTANEOUS BIVENTRICULAR MECHANICAL SUPPORT IN POST INFARCTION VENTRICULAR SEPTAL RUPTURE: MECHANICAL SUPPORT FOR A MECHANICAL CATASTROPHE
26. NON-EMERGENT PERCUTANEOUS CORONARY INTERVENTION ON AN UNPROTECTED LEFT MAIN CORONARY ARTERY SUPPORTED WITH IMPELLA® HEART PUMP IN PATIENTS INELIGIBLE FOR SURGICAL REVASCULARIZATION
27. TCT-100 Feasibility of Early Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The Detroit Cardiogenic Shock Initiative
28. TCT-608 Contemporary Use and Outcomes Associated with Rotational versus Orbital Atherectomy in Percutaneous Coronary Interventions: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
29. TCT-513 The Impella Micro-axial Flow Catheter is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis from the Global cVAD Registry
30. USE OF ULTRASOUND ASSISTED CATHETER DIRECTED THROMBOLYSIS IN TREATMENT OF AORTIC THROMBI
31. TRANSCATHETER VERSUS SURGICAL AORTIC VALVE REPLACEMENT IN DIABETES MELLITUS: FROM THE NATIONWIDE INPATIENT SAMPLE
32. ULTRASOUND ASSISTED CATHETER DIRECTED THROMBOLYSIS AND PERCUTANEOUS RIGHT VENTRICULAR MECHANICAL ASSIST DEVICE FOR THE MANAGEMENT OF MASSIVE PULMONARY EMBOLISM WITH REFRACTORY RIGHT VENTRICULAR FAILURE: PLAYING CHESS WITH PULMONARY EMBOLISM
33. TCT-24 Global cVAD Registry: A global initiative in percutaneous circulatory support From the cVAD Steering Committee on behalf of all cVAD Investigators
34. TCT-121 Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Insights from the cVAD Registry
35. TCT-127 Prior Coronary Artery Bypass Graft Surgery and Hemodynamically Supported High Risk Percutaneous Coronary Intervention: Observations from The PROTECT II Randomized Trial and The cVAD Registry
36. COST VERSUS CONTRAINDICATION: THE COMPARATIVE SAFETY OF ABCIXIMAB VERSUS EPTIFIBATIDE IN PATIENTS ON DIALYSIS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM
37. ASSOCIATION OF ANEMIA WTH OUTCOMES IN PATIENTS UNDERGOING PERCUTANEOUS PERIPHERAL VASCULAR DISEASE INTERVENTION: INSIGHTS FROM THE BMC2 VIC (BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM VASCULAR INTERVENTIONS COLLABORATIVE) REGISTRY
38. THE COMPARATIVE SAFETY OF BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PATIENTS ON DIALYSIS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM
39. TCT-824 Statewide Variability in Radiation Doses Exceeding 5 Gy During Percutaneous Coronary Intervention: Data from the Blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2) Registry
40. TCT-20 Use of a Percutaneous Left Ventricular Assist Device for High Risk Percutaneous Coronary Interventions. Clinical Trial versus Real World Experience
41. 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery
42. CLINICAL OUTCOMES OF MANUAL ASPIRATION THROMBECTOMY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: AN UPDATED META-ANALYSIS
43. CULPRIT-VESSEL VERSUS COMPLETE REVASCULARIZATION DURING PRIMARY ANGIOPLASTY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: AN UPDATED META-ANALYSIS
44. TCT-253 The Deleterious Implications of Contrast Induced Nephropathy in Patients Undergoing Peripheral Vascular Intervention: Observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium Vascular Interventions Collaborative (BMC2 VIC)
45. TCT-786 In-Hospital Outcomes of balloon aortic valvuloplasty and percutaneous coronary intervention during the same hospitalization in the US
46. Peripartum Cardiomyopathy
47. Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery
48. PERCUTANEOUS VASCULAR INTERVENTION MARKET TRENDS: BULLISH ON LEGS, BEARISH ON RENALS- THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM EXPERIENCE
49. TCT-444 The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry
50. Primary Percutaneous Coronary Intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.